uterine carcinosarcoma (Cancer)
Information
- Disease name
- uterine carcinosarcoma
- Disease ID
- DOID:6171
- Description
- "A uterine body mixed cancer that has_material_basis_in both endometrial carcinoma and sarcoma." [url:http\://cancergenome.nih.gov/cancersselected/UterineCarcinosarcoma, url:http\://en.wikipedia.org/wiki/Carcinosarcoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05229601 | Active, not recruiting | Phase 1 | A Study of HFB301001 in Adult Patients With Advanced Solid Tumors | April 20, 2022 | January 2025 |
| NCT00075400 | Completed | Phase 2 | Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer | January 2004 | July 2010 |
| NCT00114218 | Completed | Phase 2 | Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer | March 2005 | |
| NCT00238121 | Completed | Phase 2 | Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer | February 2005 | July 2010 |
| NCT00245102 | Completed | Phase 2 | Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | September 2005 | March 2011 |
| NCT00390234 | Completed | Phase 2 | Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma | September 2006 | August 2013 |
| NCT00478426 | Completed | Phase 2 | Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | April 30, 2007 | February 12, 2019 |
| NCT00659360 | Completed | Phase 2 | AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma | February 2008 | November 2012 |
| NCT00687687 | Completed | Phase 2 | Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma | May 2008 | December 2011 |
| NCT00025506 | Completed | Phase 2 | Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus | September 2001 | January 2013 |
| NCT01010126 | Completed | Phase 2 | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer | September 8, 2009 | March 13, 2017 |
| NCT01168232 | Completed | Phase 2 | Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer | September 7, 2010 | November 26, 2013 |
| NCT03694262 | Completed | Phase 2 | The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) | July 19, 2019 | April 5, 2023 |
| NCT01247571 | Completed | Phase 2 | Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer | January 2011 | January 2016 |
| NCT05902988 | Recruiting | Phase 1/Phase 2 | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | October 18, 2023 | June 2026 |
| NCT04802876 | Recruiting | Phase 2 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors | April 12, 2021 | March 31, 2027 |
| NCT05147558 | Recruiting | Phase 2 | A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma | December 23, 2021 | December 23, 2024 |
| NCT05619913 | Recruiting | Phase 2 | EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma | May 22, 2023 | December 2026 |
| NCT01367301 | Terminated | N/A | Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer | July 8, 2011 | August 15, 2018 |
| NCT01061606 | Terminated | Phase 2 | Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus | January 2010 | October 2012 |
| NCT00954174 | Unknown status | Phase 3 | Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer | August 17, 2009 | |
| NCT03902379 | Withdrawn | N/A | Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer | July 27, 2016 | May 31, 2020 |
- Disase is a (Disease Ontology)
- DOID:4114
- Cross Reference ID (Disease Ontology)
- GARD:12335
- Cross Reference ID (Disease Ontology)
- NCI:C42700
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:702369008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0280630
- Exact Synonym (Disease Ontology)
- mixed mullerian sarcoma of uterus